0
Your cart

Your cart is empty

Books > Business & Economics > Business & management > Ownership & organization of enterprises

Buy Now

Economics and Management in the Biopharmaceutical Industry in the USA - Evolution and Strategic Change (Paperback) Loot Price: R1,249
Discovery Miles 12 490
Economics and Management in the Biopharmaceutical Industry in the USA - Evolution and Strategic Change (Paperback): Rachel Kim

Economics and Management in the Biopharmaceutical Industry in the USA - Evolution and Strategic Change (Paperback)

Rachel Kim

Series: Routledge Studies in the Economics of Business and Industry

 (sign in to rate)
Loot Price R1,249 Discovery Miles 12 490 | Repayment Terms: R117 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

From a managerial perspective, the biopharmaceutical industry represents a competitive, fast-changing, intellectually-powered, innovation-driven sector. Many management scholars have studied this discontinuous era to make sense of strategic behavior and the cognition of firms and top managers. A past look at the biopharmaceutical industry provides answers to questions that most managers have. For example, what options do you have and what actions do you take when new firms enter your industry? In the 1970s, new biotechnology firms, funded by venture capitalists, appeared in the pharmaceutical industry with new knowledge. Successful pharmaceutical firms decided to collaborate with the new entrants and forge relationships to develop and create new, biotechnology engineered drugs. Thus, the addition of new biotechnology firms ushered in a new business model based on strategic alliances. Strategic alliances have now become an industrial norm called open innovation. The author looks at the historical path of the biopharmaceutical industry, particularly in the United States. While the pharmaceutical industry's main contributions to society are substantial, there are pressing challenges the industry must face, such as an increase in infectious disease outbreaks or the global aging population, which require new types of care, additionally, mental health care and prescription painkiller addiction are persistent issues with economic repercussions to both federal and local governments. This book presents a holistic view of the biopharmaceutical industry, putting it in a historical context. It will best serve those who are eager to learn about this dynamic, fast-evolving industry and who would like to tackle current biopharmaceutical industry issues in the United States and be prepared for future industry challenges.

General

Imprint: Routledge
Country of origin: United Kingdom
Series: Routledge Studies in the Economics of Business and Industry
Release date: September 2020
First published: 2019
Authors: Rachel Kim
Dimensions: 234 x 156mm (L x W)
Format: Paperback
Pages: 142
ISBN-13: 978-0-367-66431-2
Categories: Books > Business & Economics > Economics > General
Books > Business & Economics > Business & management > International business
Books > Professional & Technical > Technology: general issues > General
Books > Professional & Technical > Environmental engineering & technology > General
Books > Business & Economics > Business & management > Ownership & organization of enterprises > General
Books > Business & Economics > Business & management > Management of specific areas > Research & development management
Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
LSN: 0-367-66431-3
Barcode: 9780367664312

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners